Fibroblast Activation Protein α Activated Tripeptide Bufadienolide Antitumor Prodrug with Reduced Cardiotoxicity.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2017-06-22

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jmedchem.6b01755PMID 28595013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo

  2016cited by this paper
• Iterative design of emetine‐based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy

  2016cited by this paper
• Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway

  2015cited by this paper
• A bufadienolide-loaded submicron emulsion for oral administration: stability, antitumor efficacy and toxicity.

  2015cited by this paper
• Pharmacokinetics and toxicology of a fibroblast activation protein (FAP)‐activated prodrug in murine xenograft models of human cancer

  2014cited by this paper
• FAP-α (Fibroblast activation protein-α) is involved in the control of human breast cancer cell line growth and motility via the FAK pathway

  2014cited by this paper
• Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia

  2013cited by this paper
• Discovery of bufadienolides as a novel class of ClC-3 chloride channel activators with antitumor activities.

  2013cited by this paper
• Synthesis and structure–activity relationships study of cytotoxic bufalin 3-nitrogen-containing-ester derivatives

  2013cited by this paper
• Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.

  2013cited by this paper
• Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug.

  2012cited by this paper
• Engineering Enzymatically Activated “Molecular Grenades” for Cancer

  2012cited by this paper
• Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway.

  2012cited by this paper
• Cleavage-site specificity of prolyl endopeptidase FAP investigated with a full-length protein substrate.

  2011cited by this paper
• Bufadienolides and their antitumor activity.

  2011cited by this paper
• Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.

  2011cited by this paper
• Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion.

  2010cited by this paper
• Drawing the PDB: Protein-Ligand Complexes in Two Dimensions.

  2010cited by this paper
• Using substrate specificity of antiplasmin-cleaving enzyme for fibroblast activation protein inhibitor design.

  2009cited by this paper
• Microbial biotransformation as a source of chemical diversity in cane toad steroid toxins.

  2009cited by this paper
• Sudden death associated with intravenous injection of toad extract.

  2009cited by this paper
• Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall‐cell lung cancer, or pancreatic cancer

  2009cited by this paper
• Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.

  2009cited by this paper
• Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin

  2009cited by this paper
• Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites.

  2008cited by this paper
• Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma.

  2008cited by this paper
• Fibroblast activation protein α identifies mesenchymal stromal cells from human bone marrow

  2008cited by this paper
• From Modeling to Medicinal Chemistry: Automatic Generation of Two‐Dimensional Complex Diagrams

  2007cited by this paper
• Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats.

  2006cited by this paper
• Human Leukemia Cells in Combination with Other Inducers and Its Potent Synergistic Effect on the Differentiation of HL60, U937, and ML1 toward Macrophage/Monocyte-like Cells Induction by Bufalin of Differentiation of Human Leukemia Cells

  2006cited by this paper
• Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein.

  2006cited by this paper
• Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly2‐Pro1‐cleaving specificity

  2006cited by this paper
• Molecular complexes at a glance: automated generation of two-dimensional complex diagrams

  2006cited by this paper
• New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus

  2005cited by this paper
• Structural and Kinetic Analysis of the Substrate Specificity of Human Fibroblast Activation Protein α*

  2005cited by this paper
• Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships.

  2004cited by this paper
• Automated Drawing of Structural Molecular Formulas under Constraints

  2004cited by this paper
• A novel plasma proteinase potentiates alpha2-antiplasmin inhibition of fibrin digestion.

  2004cited by this paper
• [Clinical observation of cinobufacini injection used to treat moderate and advanced primary liver cancer].

  2003cited by this paper
• Atypical kinetic profiles in drug metabolism reactions.

  2002cited by this paper
• Cardiac toxicity of resibufogenin: electrophysiological evidence.

  2001cited by this paper
• Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.

  1994cited by this paper
• Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers.

  1992cited by this paper
• Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers.

  1990cited by this paper

• The multifaceted antineoplastic effects of arenobufagin against human cancers.

  2026cites this paper
• Decoding tumors from fibroblast activation protein: A review of the latest diagnostic and therapeutic prospects.

  2025cites this paper
• Integrated transcriptomic and proteomic analysis of hepatotoxic effects of Venenum Bufonis in zebrafish.

  2025cites this paper
• Non-peptidic natural products that target and modulate oxytocin and arginine vasopressin receptors: Opportunities and challenges.

  2025cites this paper
• Arenobufagin suppresses the progression of early-stage hepatocellular carcinoma by inhibiting EpCAM-mediated tumor stemness

  2025cites this paper
• Inflammation and cancer: friend or foe?

  2024cites this paper
• Arenobufagin-loaded PEG-PLA nanoparticles for reducing toxicity and enhancing cancer therapy

  2023cites this paper
• Design, Synthesis, and Evaluation of 18F-Labeled Tracers Targeting Fibroblast Activation Protein for Brain Imaging.

  2023cites this paper
• Research status of indole-modified natural products.

  2023cites this paper
• Establishment of FAP-overexpressing Cells for FAP-targeted Theranostics

  2023cites this paper
• Discovery of Novel 3,11‐Bispeptide Ester Arenobufagin Derivatives with Potential in Vivo Antitumor Activity and Reduced Cardiotoxicity

  2023cites this paper
• Nanocrystals with different stabilizers overcome the mucus and epithelial barriers for oral delivery of multicomponent Bufadienolides.

  2022cites this paper
• FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment

  2022cites this paper
• Bufadienolides originated from toad source and their anti-inflammatory activity

  2022cites this paper
• Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy

  2022influential citation
• Targeting cancer-associated fibroblasts: Challenges, opportunities and future directions.

  2022cites this paper
• Synthesis and anticancer activity of Boc-Gly-Pro dipeptide-annonaceous acetogenin prodrugs targeting fibroblast activation protein or other hydrolytic enzymes

  2022cites this paper
• Natural cururu toad (Rhinella sp.) poisoning in a free-ranging lesser grison (Galictis cuja): Outcomes in a new susceptible predator with a novel peptide description.

  2022cites this paper
• Fibroblast activation protein alpha: Comprehensive detection methods for drug target and tumor marker.

  2022cites this paper
• Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?

  2022cites this paper
• Monitoring the mechanism of anti-cancer agents to inhibit colorectal cancer cell proliferation: Enzymatic biosensing of glucose combined with molecular docking.

  2021cites this paper
• Long-Lasting Bioluminescence Imaging of the Fibroblast Activation Protein by an Amphiphilic Block Copolymer-Based Probe.

  2021cites this paper
• Risk Compounds, Preclinical Toxicity Evaluation, and Potential Mechanisms of Chinese Materia Medica–Induced Cardiotoxicity

  2021cites this paper
• A Novel Chemiluminescence Probe for Sensitive Detection of Fibroblast Activation Protein-Alpha In Vitro and in Living Systems.

  2021cites this paper
• Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review

  2021cites this paper
• Synthesis and Preliminary Evaluation of 131I-Labeled FAPI Tracers for Cancer Theranostics.

  2021cites this paper
• Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives

  2021cites this paper
• Novel Strategies for Solubility and Bioavailability Enhancement of Bufadienolides

  2021cites this paper
• Total synthesis, chemical modification and structure-activity relationship of bufadienolides.

  2020cites this paper
• Discovery of 3-Peptide Substituted Arenobufagin Derivatives as Potent Antitumor Agents with Low Cardiotoxicity.

  2020cites this paper
• Fibroblast activation protein-α-adaptive micelles deliver anti-cancer drugs and reprogram stroma fibrosis.

  2020cites this paper
• Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy.

  2020cites this paper
• 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway.

  2020cites this paper
• Molecular mechanisms of bufadienolides and their novel strategies for cancer treatment.

  2020cites this paper
• Cytotoxic bufadienolides from the leaves of a medicinal plant Melianthus comosus collected in South Africa.

  2020cites this paper
• Natural products and their derivatives: Promising modulators of tumor immunotherapy

  2020cites this paper
• Cytotoxic Bufadienolides from the Leaves of Melianthus major.

  2020cites this paper
• Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications.

  2020cites this paper
• Autofluorescence-free chemo/biosensing in complex matrixes based on persistent luminescence nanoparticles

  2019cites this paper
• Affinity-based Protein Profiling Reveals Cellular Targets of Photoreactive Anticancer Inhibitors.

  2019cites this paper
• Chemical Profile and Multicomponent Quantitative Analysis for the Quality Evaluation of Toad Venom from Different Origins

  2019cites this paper
• Bufadienolides induce apoptosis and autophagy by inhibiting the AKT signaling pathway in melanoma A‑375 cells.

  2019cites this paper
• Copper-Catalyzed Intermolecular [4 + 2] Annulation Enabled by Internal Oxidant-Promoted C(sp3)-H Functionalization: Access to 3-Trifluoromethylated 3-Hydroxy-cyclohexan-1-ones.

  2019cites this paper
• Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom.

  2019cites this paper
• Ervadivamines A and B, Two Unusual Trimeric Monoterpenoid Indole Alkaloids from Ervatamia divaricata.

  2018cites this paper
• Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics

  2018cites this paper
• Afterglow Resonance Energy Transfer Inhibition for Fibroblast Activation Protein-α Assay.

  2018cites this paper
• Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin.

  2018cites this paper
• Targeting fibroblast activation protein in cancer - Prospects and caveats.

  2018cites this paper